Johnson & Johnson Form 4: Pinto acquires 175.493 Deferred Share Units
Rhea-AI Filing Summary
Daniel E. Pinto, a director of Johnson & Johnson (JNJ), acquired 175.493 Deferred Share Units (DSUs) on 09/09/2025 under the company's Amended and Restated Deferred Fee Plan for Directors. Each DSU equals the fair market value of one share of JNJ common stock at the business day before settlement and will be settled in cash when Mr. Pinto's directorship ends. The reported per-unit price for the DSUs is $178.07, resulting in 175.493 units held directly after the transaction. The Form 4 was filed and signed on 09/11/2025.
Positive
- Acquisition of 175.493 DSUs under the Issuer's deferred fee plan recorded on 09/09/2025
- DSUs settle in cash and each unit represents the fair market value of one JNJ common share
- Per-unit value reported as $178.07, with 175.493 units held directly after the transaction
Negative
- None.
Insights
TL;DR: Director acquired cash-settled DSUs worth 175.493 units at $178.07 each; non-cash deferral of compensation.
The transaction records a routine director compensation deferral: 175.493 Deferred Share Units were acquired under the issuer's deferred fee plan and are to be settled in cash upon termination of the reporting person's directorship. This is a non-derivative, direct holding and does not reflect an equity sale or option exercise. The filing does not disclose any sales, option grants, or changes to outstanding equity beyond the DSU acquisition.
TL;DR: Standard governance practice—director elected cash-settled DSUs for retainer deferral; no unusual terms disclosed.
The disclosure indicates use of the company's Amended and Restated Deferred Fee Plan for Directors to defer cash retainer into Deferred Share Units. Each DSU represents the fair market value of one share at settlement and will be paid in cash upon termination of directorship. The filing is routine and complies with Section 16 reporting requirements; no related-party or indirect ownership issues are indicated.